Difference between revisions of "Caspase-1"

From Cysteinome
Jump to: navigation, search
(Created page with "{| align="left" | __TOC__ |} {{#invoke:InfoboxforTarget|run|CASP-1|[https://www.uniprot.org/uniprot/P29466 P29466]|Homo sapiens|Cys285|[http://pfam.xfam.org/family/PF00619...")
 
(Structural Information)
Line 31: Line 31:
 
==Structural Information==
 
==Structural Information==
 
*Known structure with covalent ligand: <br/>
 
*Known structure with covalent ligand: <br/>
[https://www.rcsb.org/structure/1ICE 1ICE], [https://www.rcsb.org/structure/3NS7 3NS7], [https://www.rcsb.org/structure/1BMQ 1BMQ], [https://www.rcsb.org/structure/1RWK 1RWK], [https://www.rcsb.org/structure/1RWM 1RWM], [https://www.rcsb.org/structure/1RWN 1RWN],<br/>[https://www.rcsb.org/structure/1RWO 1RWO], [https://www.rcsb.org/structure/1RWP 1RWP], [https://www.rcsb.org/structure/1RWV 1RWV], [https://www.rcsb.org/structure/1RWW 1RWW], [https://www.rcsb.org/structure/1RWX 1RWX], [https://www.rcsb.org/structure/2H4W 2H4W],<br/>[https://www.rcsb.org/structure/2H4Y 2H4Y], [https://www.rcsb.org/structure/2H51 2H51], [https://www.rcsb.org/structure/2H54 2H54], [https://www.rcsb.org/structure/2HBQ 2HBQ], [https://www.rcsb.org/structure/2HBR 2HBR], [https://www.rcsb.org/structure/2HBY 2HBY],<br/>[https://www.rcsb.org/structure/2HBZ 2HBZ]
+
[https://www.rcsb.org/structure/1ICE 1ICE], [https://www.rcsb.org/structure/3NS7 3NS7], [https://www.rcsb.org/structure/1BMQ 1BMQ], [https://www.rcsb.org/structure/1RWK 1RWK], [https://www.rcsb.org/structure/1RWM 1RWM], [https://www.rcsb.org/structure/1RWN 1RWN],<br/>[https://www.rcsb.org/structure/1RWO 1RWO], [https://www.rcsb.org/structure/1RWP 1RWP], [https://www.rcsb.org/structure/1RWV 1RWV], [https://www.rcsb.org/structure/1RWW 1RWW], [https://www.rcsb.org/structure/1RWX 1RWX], [https://www.rcsb.org/structure/2H4W 2H4W],<br/>[https://www.rcsb.org/structure/2H4Y 2H4Y], [https://www.rcsb.org/structure/2H51 2H51], [https://www.rcsb.org/structure/2H54 2H54], [https://www.rcsb.org/structure/2HBQ 2HBQ], [https://www.rcsb.org/structure/2HBR 2HBR], [https://www.rcsb.org/structure/2HBY 2HBY], [https://www.rcsb.org/structure/2HBZ 2HBZ]
  
 
*Protein structure:
 
*Protein structure:

Revision as of 19:17, 18 August 2019

Basic Information
Short Name CASP-1
UNP ID P29466
Organism Homo sapiens
Cys Site Cys285
Family/Domain Caspase recruitment domain,
Peptidase C14A family]
Known Ligand Ligand list
Function Type Protease

Summary

Protein Function

Caspase-1 (also known as interleukin 1β-converting enzyme or ICE) is expressed as a procaspase-1 zymogen that is processed into a catalytically competent form through autoproteolysis induced by protein oligomerization in vitro, but may require caspase-5 for efficient activation in vivo. It cleaves IL-1β between an Asp and an Ala, releasing the mature cytokine which is involved in a variety of inflammatory processes. Caspase-1 is important for defense against pathogens. It could cleaves and activates sterol regulatory element binding proteins (SREBPs). It also can promote apoptosis. (From Uniprot, PMID: 16511067)

Cys Function & Property

Cys285 is one of the active sites of CASP-1.

  • Hydrophobic property:
569-hydro.png
  • SASA:
Cys285: 11.718 A^2

Protein Sequence

MADKVLKEKR KLFIRSMGEG TINGLLDELL QTRVLNKEEM EKVKRENATV
MDKTRALIDS VIPKGAQACQ ICITYICEED SYLAGTLGLS ADQTSGNYLN
MQDSQGVLSS FPAPQAVQDN PAMPTSSGSE GNVKLCSLEE AQRIWKQKSA
EIYPIMDKSS RTRLALIICN EEFDSIPRRT GAEVDITGMT MLLQNLGYSV
DVKKNLTASD MTTELEAFAH RPEHKTSDST FLVFMSHGIR EGICGKKHSE
QVPDILQLNA IFNMLNTKNC PSLKDKPKVI IIQACRGDSP GVVWFKDSVG
VSGNLSLPTT EEFEDDAIKK AHIEKDFIAF CSSTPDNVSW RHPTMGSVFI
GRLIEHMQEY ACSCDVEEIF RKVRFSFEQP DGRAQMPTTE RVTLTRCFYL
FPGH

Structural Information

  • Known structure with covalent ligand:

1ICE, 3NS7, 1BMQ, 1RWK, 1RWM, 1RWN,
1RWO, 1RWP, 1RWV, 1RWW, 1RWX, 2H4W,
2H4Y, 2H51, 2H54, 2HBQ, 2HBR, 2HBY, 2HBZ

  • Protein structure:
569.png

Related Pathway

Experimental Evidence

Crystallography

Reference

  1. Lee J, Bogyo M. Synthesis and evaluation of aza-peptidyl inhibitors of the lysosomal asparaginyl endopeptidase, legumain[J]. Bioorganic & medicinal chemistry letters, 2012, 22(3): 1340-1343. 22243962
  2. Dall E, Brandstetter H. Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation[J]. Proceedings of the National Academy of Sciences, 2013, 110(27): 10940-10945. 23776206